Filer Snapshot

Pharmagreen Biotech Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001435181.

Entity Type

Company

Total Filings

104

Latest Filing

01 Dec 2023

Industry

Airports, Flying Fields & Airport Terminal Services

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC filing 15-12G

15-12G filed on 01 Dec 2023 for CIK 0001435181.

View Source Filing
Symbol
PHBI on OTC
Business address
2987 Blackbear Court, Coquitlam, British Columbia, Canada, V3E3A2
State of incorporation
NV
Fiscal year end
30 September
Former names
Air Transport Group Holdings, Inc. (to 03 Feb 2017), Azure International, Inc. (to 02 Sep 2008)

Quick Takeaways

  • Pharmagreen Biotech Inc. is an SEC filer tracked under CIK 0001435181.
  • 104 filings are listed on this profile.
  • Common form coverage includes 15-12G, 10-Q, 8-K and more.

What Changed

  • Latest filing: 15-12G filed on 01 Dec 2023.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing 15-12G

15-12G filed on 01 Dec 2023 for CIK 0001435181.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 15-12G can change the filing history, ownership context, or next research path for Pharmagreen Biotech Inc..

Latest source-backed update
15-12G filed 01 Dec 2023
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: 15-12G filed 01 Dec 2023.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Latest update

What changed recently for Pharmagreen Biotech Inc.

New fact period available

Latest financial period: Q2 2023. Open the source-backed page to inspect the fresh filing or facts context.

Update date

14 Aug 2023

Page type

Company facts

Latest period

Q2 2023

SEC-backed company facts were refreshed from filings filed on 14 Aug 2023.

Benchmark Context

Benchmark context for this company

Pharmagreen Biotech Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q2 2023. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 14 Aug 2023.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Company intelligence

Research Pharmagreen Biotech Inc. from filings to ownership signals

Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.

Active modules

2/5

Available company intelligence paths on this page.

Filings

104

SEC submissions provide the evidence trail.

Ownership context

0/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Save the company so the next source-backed change has a clear place to bring you back.

Best-of company intelligence workflow

What changed?

Start with the latest filing and active ownership modules before opening older table rows.

Why might it matter?

Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.

Where is evidence?

Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.

What to watch next?

Save the company so watchlists can bring you back when the next filing-backed update lands.

SEC-verifiable company research path

Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Explore

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Browse latest insider filings

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch Pharmagreen Biotech Inc. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

Pharmagreen Biotech Inc. has filed 104 SEC EDGAR filings since 02 Jun 2008. Common forms include 15-12G, 10-Q, 8-K, NT 10-Q and more.

Latest Filings

Recent SEC filings for Pharmagreen Biotech Inc. with direct links to document and filing folders.

15-12G File 000-56090

15-12G

Filing date
01 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q

Filing date
12 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-56090

NT 10-K

Filing date
28 Dec 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q

Filing date
14 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
253G2 File 024-11505

253G2

Filing date
04 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
QUALIF File 024-11505

QUALIF filing

Filing date
24 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A/A File 024-11505

1-A/A filing

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8K

Filing date
24 Aug 2021
Reporting date
24 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A/A File 024-11505

1-A/A filing

Filing date
16 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8-K

Filing date
23 Jun 2021
Reporting date
13 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A/A File 024-11505

1-A/A filing

Filing date
22 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-56090

PHARMAGREEN FORM 10-K/A

Filing date
10 Jun 2021
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56090

PBI FORM 10-Q

Filing date
24 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
8-K File 000-56090

PHARMAGREEN FORM 8-K

Filing date
17 May 2021
Reporting date
17 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-56090

FORM 12B-25

Filing date
14 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A File 024-11505

1-A filing

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8-K

Filing date
22 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-238126

PHARMAGREEN BIOTECH - REQUEST FOR WITHDRAWAL OF FORM S-1

Filing date
03 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-56090

FORM 10-Q/A

Filing date
23 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56090

FORM 10-Q FOR THREE MONTHS ENDED DECEMBER 31, 2020

Filing date
22 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-56090

FORM 12B-25

Filing date
12 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-56090

FORM 10-K FOR YEAR ENDED SEPTEMBER 30, 2020

Filing date
08 Jan 2021
Reporting date
30 Sep 2020
Next action
Verify source filing
NT 10-K File 000-56090

FORM 12B-25

Filing date
29 Dec 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-56090

DEFINITIVE SCHEDULE 14C

Filing date
28 Oct 2020
Reporting date
15 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8-K

Filing date
20 Oct 2020
Reporting date
19 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8-K

Filing date
16 Oct 2020
Reporting date
14 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-56090

SCHEDULE 14C PRELIMINARY

Filing date
16 Oct 2020
Reporting date
15 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56090

10-Q filing

Filing date
19 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q filing

Filing date
12 Aug 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

8-K filing

Filing date
12 Aug 2020
Reporting date
07 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

PHARMAGREEN FORM 8-K

Filing date
21 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-56090

DEFINITIVE INFORMATION STATEMENT

Filing date
23 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-56090

PRELIMINARY INFORMATION STATEMENT

Filing date
12 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8-K

Filing date
22 May 2020
Reporting date
22 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56090

FORM 10-1 FOR SIX MONTHS ENDED MARCH 31, 2020

Filing date
19 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q

Filing date
13 May 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-238126

FORM S-1 REGISTRATION STATEMENT

Filing date
08 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

CURRENT REPORT DATED FEBRUARY 28, 2020

Filing date
04 Mar 2020
Reporting date
28 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-56090

QUARTERLY REPORT FOR PERIOD ENDED DECEMBER 31, 2019

Filing date
18 Feb 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
NT 10-Q File 000-56090

NT 10-Q

Filing date
14 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

CURRENT REPORT DATED JANUARY 23, 2020

Filing date
24 Jan 2020
Reporting date
23 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-56090

ANNUAL REPORT FOR PERIOD ENDED SEPTEMBER 30, 2019

Filing date
30 Dec 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
8-K File 000-56090

CURRENT REPORT DATED NOVEMBER 29, 2019

Filing date
02 Dec 2019
Reporting date
29 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

FORM 8-K DATED NOVEMBER 8, 2019

Filing date
08 Nov 2019
Reporting date
08 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56090

CURRENT REPORT DATED SEPTEMBER 3, 2019

Filing date
11 Sep 2019
Reporting date
11 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-56090

AMENDMENT NO. 1 QUARTERLY REPORT FOR PERIOD ENDED JUNE 30, 2019

Filing date
06 Sep 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-56090

FORM 8-A12G

Filing date
05 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-151350

QUARTERLY REPORT FOR PERIOD ENDED JUNE 30, 2019

Filing date
19 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
NT 10-Q File 333-151350

NOTIFICATION OF LATE FILING

Filing date
15 Aug 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-230413

EFFECT filing

Filing date
15 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-230413

S-1/A filing

Filing date
24 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-230413

FORM S-1, AMENDMENT NO. 3

Filing date
11 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
06 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-230413

FORM S-1, AMENDMENT NO. 2

Filing date
05 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-230413

FORM S-1 A1

Filing date
10 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-230413

REGISTRATION STATEMENT

Filing date
20 Mar 2019
Reporting date
Not listed
Next action
Verify source filing
15-15D File 333-151350

15-15D filing

Filing date
03 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-151350

CURRENT REPORT DATED 12-24-09

Filing date
19 Jan 2010
Reporting date
24 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

Pharmagreen Biotech Inc. files with the SEC under CIK 0001435181. This page aggregates EDGAR filings and related ownership activity.

Industry: Airports, Flying Fields & Airport Terminal Services.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .